How has Solventum's increase (decrease) in accounts receivable changed year-over-year?

Solventum's increase (decrease) in accounts receivable increased by 666.7% year-over-year, from -$6M to $34M.

What is the long-term trend for Solventum's increase (decrease) in accounts receivable?

Over 2 years (2022 to 2025), Solventum's increase (decrease) in accounts receivable has grown at a 6.1% compound annual growth rate (CAGR), from $32M to -$36M.

Solventum SOLV Increase (Decrease) in Accounts Receivable

Increase (Decrease) in Accounts Receivable at other companies

3MMMM

$248M-4.2%

Baxter InternationalBAX

-$152M-485%

Globus MedicalGMED

——

Medline, Inc. MDLN

——

Other financials

Income statement

See full

Revenue$2.0B-3.0%

Gross profit$1.1B-1.5%

Operating income$81.0M-46.7%

Net income$13.0M-90.5%

EPS (diluted)$0.07-91.0%

Balance sheet

See full

Cash & equivalents$561.0M+5.1%

Total debt$5.8B-26.8%

Total equity$5.0B+52.3%

Total assets$14.1B-3.0%

Cash flow

See full

Operating cash flow-$189.0M-752%

CapEx$84.0M-22.9%

Free cash flow-$273.0M-241%

Valuation

See full

Market cap$13.06B-13.9%

Enterprise value$18.29B-19.4%

P/E9.1×-30.9×

P/S1.6×-0.2×

Profitability

See full

Gross margin53.7%-0.9pp

Operating margin25.5%+15.8pp

Net margin17.3%+12.8pp

FCF margin4.6%-13.9pp

Returns & leverage

See full

Return on equity34.8%+24.1pp

Debt / equity1.2×-1.3×

Current ratio1.1×-0.1×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Solventum's increase (decrease) in accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Solventum's increase (decrease) in accounts receivable?: Solventum (SOLV) reported increase (decrease) in accounts receivable of $34M in Q1 2026.
How has Solventum's increase (decrease) in accounts receivable changed year-over-year?: Solventum's increase (decrease) in accounts receivable increased by 666.7% year-over-year, from -$6M to $34M.
What is the long-term trend for Solventum's increase (decrease) in accounts receivable?: Over 2 years (2022 to 2025), Solventum's increase (decrease) in accounts receivable has grown at a 6.1% compound annual growth rate (CAGR), from $32M to -$36M.